Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection (CENV3)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2012 by National Liver Institute, Egypt.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Mostafa K. El Awady, National Liver Institute, Egypt Identifier:
First received: June 27, 2012
Last updated: October 30, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)